News by Subject Medicine & Health

Scientists at Huntsman Cancer Institute at the University of Utah report today the development of new models to study molecular characteristics of tumors of the lung and pancreas that are driven by mutations in a gene named NTRK1. The findings were published today in the journal Cell Reports.

In an analysis of how regulators review pesticides for their potential to cause cancer, researchers at Silent Spring Institute identified more than two dozen registered pesticides that were linked with mammary gland tumors in animal studies. The new findings raise concerns about how the US Environmental Protection Agency (EPA) approves pesticides for use and the role of certain pesticides in the development of breast cancer.

20 percent of the middle-aged UK South Asian population may have a very severe vitamin D deficiency, a new study in the British Journal of Nutrition reports. Such deficiency can lead to health problems such as osteomalacia (softening of the bones) and other chronic diseases.

Researchers from Josep Carreras Leukemia Research Institute participate in an international study that confirms for the first time that mutation of the two TP53 gene's copies is associated with a worse prognosis in myelodysplastic syndromes, a group of blood cancers a more frequent in elderly population. The results of this study have been published in Nature Medicine journal and represent an advance in the diagnosis and treatment of this type of hematological cancer.

Changes in the number of patients with newly identified cancer before and during the COVID-19 pandemic in the United States are examined in this observational study.

A potentially safer, more effective chemotherapy treatment for patients with blood-related cancers, such as leukemia, who need a particular bone marrow transplant procedure is under study at the University of Arizona Health Sciences. The procedure is known as a haploidentical (half-matched) bone marrow transplantation, or "haplo-BMT," providng an alternate source of stem cells for patients needing a bone marrow transplant but unable to find a perfect or near-perfect donor match for human leukocyte antigens.